Pfizer vaccine booster
US approves Pfizer-BioNTech Covid booster for teenagers aged 16 and 17
Washington/IBNS: The United States Food and Drug Administration (FDA) on Thursday authorised the Pfizer-BioNTech Covid booster to include 16- and 17-year-olds, amid growing concern over the Omicron variant.
The FDA's decision comes a day after the companies released the results of lab tests that showed three doses of the jab apparanetly is more effective against Omicron variant.
The expanded emergency use authorization (EUA) for the vaccine, which applies six months after the primary inoculation series, is likely to be quickly reviewed.
The Centers for Disease Control and Prevention (CDC) will further ratify the approval.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
